Celanese to cease operations at Lanaken facility, layoff 160 employees-February 2024-www.financetom.com

Celanese to cease operations at Lanaken facility, layoff 160 employees

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Celanese to cease operations at Lanaken facility, layoff 160 employees

Oct 28, 2025 5:55 AM

Oct 28 (Reuters) - Chemical firm Celanese said on

Tuesday it plans to cease operations at its acetate tow facility

in Lanaken during the second half of 2026.

The company also said the decision may impact about 160

employees from manufacturing and support functions at the site.

Previous page： AerCap says narrow-body market won't reach equilibrium until 2029-2030 Next page： Polestar Offers North American Customers Access to 17,800 Tesla Superchargers

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

AerCap says narrow-body market won't reach equilibrium until 2029-2030

Nov 3, 2024

DUBLIN, Oct 30 (Reuters) - The world's largest aircraft lessor AerCap ( AER ) does not expect the market for narrowbody aircraft to reach equilibrium until 2029 or 2030, CEO Aengus Kelly told analysts on Wednesday following the release of quarterly results. Airlines will continue to use aircraft for longer and the demand for used aircraft will remain strong for...

Polestar Offers North American Customers Access to 17,800 Tesla Superchargers

Nov 3, 2024

10:24 AM EDT, 10/30/2024 (MT Newswires) -- Polestar (PSNY) said Wednesday it is offering its customers in North America access to 17,800 Tesla (TSLA) Superchargers. The company said it will include the North American Charging Standard, or NACS inlet in its future models, while current owners can obtain a NACS adapter from their local Polestar service center. Additionally, Polestar said...

Avanos Medical Q3 Adjusted Earnings Rise, Revenue Falls

Nov 3, 2024

09:45 AM EDT, 10/30/2024 (MT Newswires) -- Avanos Medical ( AVNS ) reported Q3 adjusted earnings from continuing operations Wednesday of $0.36 per diluted share, up from $0.30 a year earlier. Analysts polled by Capital IQ expected $0.35. Net sales for the quarter ended Sept. 30 were $170.4 million, down from $171.3 million a year earlier. Analysts surveyed by Capital...

--Street Color: Astrazeneca China President Leon Wang Currently Under Investigation by Chinese Authorities

Nov 3, 2024

09:46 AM EDT, 10/30/2024 (MT Newswires) -- Price: 71.76, Change: -3.47, Percent Change: -4.61 ...